Aktis Oncology Inc (AKTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 37,159 | 29,513 |
| Marketable Securities | 260,009 | 68,349 |
| Other current assets | 3,685 | 2,342 |
| TOTAL | $300,853 | $100,204 |
| Non-Current Assets | ||
| PPE Net | 10,527 | 7,165 |
| Other Non-Current Assets | 4,457 | 1,227 |
| TOTAL | $14,984 | $8,392 |
| Total Assets | $326,181 | $122,355 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 1,918 | 957 |
| Accrued Expenses | 6,331 | 3,752 |
| Other current liabilities | 9,277 | 0 |
| TOTAL | $18,822 | $6,237 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 0 | 500 |
| TOTAL | $51,039 | $500 |
| Total Liabilities | $80,575 | $18,611 |
| Shareholders' Equity | ||
| Retained earnings | -92,833 | -48,853 |
| Other shareholders' equity | 333,533 | 150,132 |
| TOTAL | $245,606 | $103,744 |
| Total Liabilities And Equity | $326,181 | $122,355 |